CSIMarket
 


Oramed Pharmaceuticals Inc   (ORMP)
Other Ticker:  
 

Oramed Pharmaceuticals Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


Return On Equity (Feb 29 2020)
II. Quarter
(Nov 30 2019)
I. Quarter
(Aug 31 2019)
IV. Quarter
(May 31 2019)
III. Quarter
(Feb 28 2019)
II. Quarter
Y / Y Equity Change -36.52 % -40.54 % -37.67 % 29.42 % -
Y / Y Net Income Change -0.35 % -40.89 % -22.08 % -6.48 % 26.92 %
Net Income (TTM) in Millions 13 13 14 15 15
Return On Equity (TTM) 67.83 % 60.37 % 60.34 % 56.14 % 59.95 %
Total Ranking # 93 # 140 # 123 # 160 # 113
Equity (TTM) in Millions 16 17 19 22 25
Seq. Equity Change -6.24 % -11.51 % -10.04 % -14.96 % -12.16 %
Seq. Net Income Change 45.03 % 11.54 % -44.01 % 10.02 % -13.97 %


Roe Comment
Oramed Pharmaceuticals Inc returned in II. Quarter 67.83 % on shareholder's equity, and it was higher than Oramed Pharmaceuticals Inc average return on equity.

ROE improved compare to previous quarter, due to net income growth.

Within Healthcare sector 17 other companies have achieved higher return on equity. While Return on equity total ranking has impoved so far to 93, from total ranking in previous quarter at 152.

What is ROE?
Return On Equity Company Ranking
Within: No.
Industry # 6
Sector # 18
Overall # 93

Return On Equity Statistics
High Average Low
89.84 %
66.02 %
55.95 %
(May 31 2018)   (Aug 31 2018)


Annual Return On Equity (Aug 31 2019)
2019
(Aug 31 2018)
2018
(Aug 31 2017)
2017
(Aug 31 2016)
2016
(Aug 31 2015)
2015
Total Equity in Millions 19 31 19 26 25
Y / Y Equity Change -37.67 % 61.72 % -26.54 % 5.49 % 19.41 %
Net Income in Millions 14 13 10 11 7
Y / Y Net Income Change 12.79 % 21.44 % -4.41 % 51.6 % 26.97 %
Return On Equity 74.02 % 40.91 % 54.48 % 41.86 % 29.13 %





Annual Roe Comment
In 2019 ROE improved to 74.02 % compare to previous year, due to net income growth.


Financial Statements
Oramed Pharmaceuticals Inc 's Equity $ 16 Millions ORMP's Balance sheet
Oramed Pharmaceuticals Inc 's Income $ 4 Millions Quarterly ORMP's Income Statement
ORMP's Income by Division See ORMP's Income by Division

More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
Roe Trends for overall market
ORMP's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for ORMP's Competitors
Return On Equity for Oramed Pharmaceuticals Inc 's Suppliers
Roe for ORMP's Customers

You may also want to know
ORMP's Roa ORMP's Inventory Turnover Ratio ORMP's Growth Rates ORMP's Dividend Statistics
ORMP's Annual Roe ORMP's Profitability Ratios ORMP's Asset Turnover Ratio ORMP's Dividend Growth
ORMP's Roi ORMP's Valuation Ratios ORMP's Financial Strength Ratios ORMP's Dividend Payout Ratio



Companies with similar Return On Equity at Feb 29 2020, within Healthcare Sector ROE
Coherus Biosciences inc   184.92 %
Eli Lilly And Company  181.18 %
Tenax Therapeutics Inc   168.81 %
Mettler Toledo International Inc  131.15 %
Semler Scientific Inc   129.26 %
National Research Corporation  114.97 %
Fitlife Brands Inc   106.58 %
Molecular Templates Inc   103.65 %
Cure Pharmaceutical Holding Corp   90.77 %
Integrated Biopharma Inc  89.67 %
Amgen Inc   75.10 %
Jounce Therapeutics Inc   74.73 %
Innoviva inc   71.94 %
Oramed Pharmaceuticals Inc   67.83 %
Zoetis Inc   61.08 %
Zynex Inc  54.91 %
Catalyst Pharmaceuticals Inc   52.28 %
Tenet Healthcare Corp  45.26 %
Biogen Inc   44.47 %
Palatin Technologies Inc  39.60 %
Alpha Pro Tech Ltd  39.03 %
Opiant Pharmaceuticals Inc   38.85 %
Merck and Co Inc   37.90 %
Boston Scientific Corporation  36.64 %
Chemed Corporation  34.23 %
Horizon Therapeutics Public Limited Company  31.80 %
Vanda Pharmaceuticals Inc   30.60 %
Corcept Therapeutics Inc  30.00 %
Neurocrine Biosciences Inc   29.48 %
Edwards Lifesciences Corporation  28.84 %



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

EQ's Profile

Stock Price

EQ's Financials

Business Description

Fundamentals

Charts & Quotes

EQ's News

Suppliers

EQ's Competitors

Customers & Markets

Economic Indicators

EQ's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071